Literature DB >> 34360910

Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.

Aline Yen Ling Wang1.   

Abstract

Modified mRNA (modRNA)-based somatic reprogramming is an effective and safe approach that overcomes the genomic mutation risk caused by viral integrative methods. It has improved the disadvantages of conventional mRNA and has better stability and immunogenicity. The modRNA molecules encoding multiple pluripotent factors have been applied successfully in reprogramming somatic cells such as fibroblasts, mesenchymal stem cells, and amniotic fluid stem cells to generate pluripotent stem cells (iPSCs). Moreover, it also can be directly used in the terminal differentiation of stem cells and fibroblasts into functional therapeutic cells, which exhibit great promise in disease modeling, drug screening, cell transplantation therapy, and regenerative medicine. In this review, we summarized the reprogramming applications of modified mRNA in iPSC generation and therapeutic applications of functionally differentiated cells.

Entities:  

Keywords:  induced pluripotent stem cells; mRNA-based reprogramming; modified mRNA; therapeutic application; transdifferentiation

Year:  2021        PMID: 34360910     DOI: 10.3390/ijms22158148

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  4 in total

Review 1.  Tumorigenicity risk of iPSCs in vivo: nip it in the bud.

Authors:  Chaoliang Zhong; Miao Liu; Xinghua Pan; Haiying Zhu
Journal:  Precis Clin Med       Date:  2022-02-03

Review 2.  Modified mRNA-Based Vaccines Against Coronavirus Disease 2019.

Authors:  Aline Yen Ling Wang
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 3.  Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine.

Authors:  Mareike S Poetsch; Anna Strano; Kaomei Guan
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

4.  Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA.

Authors:  Jian Xu; Zhihua Yang; Rui Wang; Fumei He; Rong Yan; Yidi Zhang; Liying Yu; Wenbin Deng; Yichu Nie
Journal:  Commun Biol       Date:  2022-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.